Immunovant Inc. Common Stock vs SK Telecom Co. Ltd. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while SK Telecom Co. Ltd. Common Stock trades at $34.15 (market cap $13.90B). The key difference: SK Telecom Co. Ltd. Common Stock is far larger — about 2.1× Immunovant Inc. Common Stock's market cap, and SK Telecom Co. Ltd. Common Stock pays a 2.73% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and SK Telecom Co. Ltd. Common Stock for 0 Days on average.
| IMVT | SKM | |
|---|---|---|
Market Cap | $6.62B | $13.90B |
Volume | 1,131,364 | 1,045,075 |
Sector | Health | Media |
52-Week High | $44.96 | $46.00 |
52-Week Low | $17.03 | $19.68 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $19.95B |
Dividend Yield | — | 2.73% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →SK Telecom is a South Korean telecommunications company providing mobile, broadband, and digital services. It also develops services in areas such as AI, cloud, and data centers.
Read more on SKM →